LCISPhyllodesTumorOvarianSuppressionOligometastasesMastodyniaIn-situCarcinomaCDK4/6InhibitorsDown-StagingAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPI3KinaseInhibitorsRADAdenocarcinomaAromataseInhibitorsNodePositiveAbsoluteRiskPalpationAxillarySamplingInvasiveBreastCancerApoptosisCheckpointInhibitorBreastCancerSERMAntibodyTherapyDimplingPalbociclibHormoneReplacementTherapyPagetDiseaseAntiemeticGeneMutationAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerHER-2CapecitabineRadiotherapyRelapseWomen ages40+ shouldhave a clinicalbreast examat least yearlyER+PARPInhibitorsCAMMastectomyEstrogenSelf-examinationAngiogenesisGenomicTestingGuaranteedRenewableInsuranceBevacizumabFibroadenomaChemotherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BilateralProphylacticMastectomyMetastasisMRIAnastrozoleMethotrexateStagingCystMultimodalityTherapyDoxorubicinProgestinMegestrolAcetateHerceptinImmunotherapyLymphNodeStatusBOCABI-RADSPrecisionMedicineBiopsyExcisionalBiopsyCachexiaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCalcificationsER-1 in 8womenHormoneReceptorStatusTriplePositiveBreastCancerKappaEpsilonCyclophosphamideAdjuvantTherapyPathologicResponseRaloxifeneCytotoxic5-FluorouracilBreastTomosynthesisCo-survivorGeneticPredispositionEGFR(epidermalgrowth factorreceptor)NeoplasmBRCAGeneNeoadjuvantTherapyMultifocalTumorsLymphoscintigraphyACChemotherapyBrachytherapyTumorGradeDocetaxelGailModelCMFChemotherapyDefinitiveSurgeryTamoxifenAlopeciaEstradiolAdvocacyGermlineMutationFamilyHistoryGeneticCounselingWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Tyrosine-KinaseInhibitorTripleNegativeBreastCancerPaclitaxelECOGScoreAyurvedaBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55LapatinibFlowCytometryLumpMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltLumpectomyNodeNegativeKi-67RateIntraductalPapillomaCytostaticDoseDenseTherapyChemopreventionPhysicalactivity mayreduce therisk of breastcancersMorpheamTORInhibitorsFISHLCISPhyllodesTumorOvarianSuppressionOligometastasesMastodyniaIn-situCarcinomaCDK4/6InhibitorsDown-StagingAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPI3KinaseInhibitorsRADAdenocarcinomaAromataseInhibitorsNodePositiveAbsoluteRiskPalpationAxillarySamplingInvasiveBreastCancerApoptosisCheckpointInhibitorBreastCancerSERMAntibodyTherapyDimplingPalbociclibHormoneReplacementTherapyPagetDiseaseAntiemeticGeneMutationAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerHER-2CapecitabineRadiotherapyRelapseWomen ages40+ shouldhave a clinicalbreast examat least yearlyER+PARPInhibitorsCAMMastectomyEstrogenSelf-examinationAngiogenesisGenomicTestingGuaranteedRenewableInsuranceBevacizumabFibroadenomaChemotherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BilateralProphylacticMastectomyMetastasisMRIAnastrozoleMethotrexateStagingCystMultimodalityTherapyDoxorubicinProgestinMegestrolAcetateHerceptinImmunotherapyLymphNodeStatusBOCABI-RADSPrecisionMedicineBiopsyExcisionalBiopsyCachexiaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCalcificationsER-1 in 8womenHormoneReceptorStatusTriplePositiveBreastCancerKappaEpsilonCyclophosphamideAdjuvantTherapyPathologicResponseRaloxifeneCytotoxic5-FluorouracilBreastTomosynthesisCo-survivorGeneticPredispositionEGFR(epidermalgrowth factorreceptor)NeoplasmBRCAGeneNeoadjuvantTherapyMultifocalTumorsLymphoscintigraphyACChemotherapyBrachytherapyTumorGradeDocetaxelGailModelCMFChemotherapyDefinitiveSurgeryTamoxifenAlopeciaEstradiolAdvocacyGermlineMutationFamilyHistoryGeneticCounselingWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Tyrosine-KinaseInhibitorTripleNegativeBreastCancerPaclitaxelECOGScoreAyurvedaBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55LapatinibFlowCytometryLumpMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltLumpectomyNodeNegativeKi-67RateIntraductalPapillomaCytostaticDoseDenseTherapyChemopreventionPhysicalactivity mayreduce therisk of breastcancersMorpheamTORInhibitorsFISH

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. LCIS
  2. Phyllodes Tumor
  3. Ovarian Suppression
  4. Oligometastases
  5. Mastodynia
  6. In-situ Carcinoma
  7. CDK4/6 Inhibitors
  8. Down-Staging
  9. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  10. PI3 Kinase Inhibitors
  11. RAD
  12. Adenocarcinoma
  13. Aromatase Inhibitors
  14. Node Positive
  15. Absolute Risk
  16. Palpation
  17. Axillary Sampling
  18. Invasive Breast Cancer
  19. Apoptosis
  20. Checkpoint Inhibitor
  21. Breast Cancer
  22. SERM
  23. Antibody Therapy
  24. Dimpling
  25. Palbociclib
  26. Hormone Replacement Therapy
  27. Paget Disease
  28. Antiemetic
  29. Gene Mutation
  30. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  31. HER-2
  32. Capecitabine
  33. Radiotherapy
  34. Relapse
  35. Women ages 40+ should have a clinical breast exam at least yearly
  36. ER+
  37. PARP Inhibitors
  38. CAM
  39. Mastectomy
  40. Estrogen
  41. Self-examination
  42. Angiogenesis
  43. Genomic Testing
  44. Guaranteed Renewable Insurance
  45. Bevacizumab
  46. Fibroadenoma
  47. Chemotherapy
  48. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  49. Bilateral Prophylactic Mastectomy
  50. Metastasis
  51. MRI
  52. Anastrozole
  53. Methotrexate
  54. Staging
  55. Cyst
  56. Multimodality Therapy
  57. Doxorubicin
  58. Progestin
  59. Megestrol Acetate
  60. Herceptin
  61. Immunotherapy
  62. Lymph Node Status
  63. BOCA
  64. BI-RADS
  65. Precision Medicine
  66. Biopsy
  67. Excisional Biopsy
  68. Cachexia
  69. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  70. Calcifications
  71. ER-
  72. 1 in 8 women
  73. Hormone Receptor Status
  74. Triple Positive Breast Cancer
  75. Kappa Epsilon
  76. Cyclophosphamide
  77. Adjuvant Therapy
  78. Pathologic Response
  79. Raloxifene
  80. Cytotoxic
  81. 5-Fluorouracil
  82. Breast Tomosynthesis
  83. Co-survivor
  84. Genetic Predisposition
  85. EGFR (epidermal growth factor receptor)
  86. Neoplasm
  87. BRCA Gene
  88. Neoadjuvant Therapy
  89. Multifocal Tumors
  90. Lymphoscintigraphy
  91. AC Chemotherapy
  92. Brachytherapy
  93. Tumor Grade
  94. Docetaxel
  95. Gail Model
  96. CMF Chemotherapy
  97. Definitive Surgery
  98. Tamoxifen
  99. Alopecia
  100. Estradiol
  101. Advocacy
  102. Germline Mutation
  103. Family History
  104. Genetic Counseling
  105. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  106. Tyrosine-Kinase Inhibitor
  107. Triple Negative Breast Cancer
  108. Paclitaxel
  109. ECOG Score
  110. Ayurveda
  111. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  112. Lapatinib
  113. Flow Cytometry
  114. Lump
  115. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  116. Lumpectomy
  117. Node Negative
  118. Ki-67 Rate
  119. Intraductal Papilloma
  120. Cytostatic
  121. Dose Dense Therapy
  122. Chemoprevention
  123. Physical activity may reduce the risk of breast cancers
  124. Morphea
  125. mTOR Inhibitors
  126. FISH